The suspension of online sales of “myopia medicine” has triggered panic buying, and parents need to treat it rationally

Recently, the eye hospital of Xingqi Eye Medicine announced the suspension of online sales of atropine eye drops, arousing concern. Because of its relieving effect on juvenile myopia, low-concentration atropine eye drops are called “myopia magic medicine” by many parents. Many parents of myopic children immediately started the stocking mode because they were worried that they would not be able to buy them. Some parents said that after brushing the phone for a day, they snapped up 24 boxes before they stopped selling, which can be used for two years. On social platforms and second-hand goods trading platforms, many people have begun to do purchasing business, and purchasing agency fees range from tens to hundreds of yuan.

Adolescent vision is a concern for many parents. In June 2020, the National Health and Medical Commission released the “China Eye Health White Paper” showing that in 2018, the overall myopia rate of children and adolescents in my country was 53.6%, ranking first in the world.

Although myopia is not a big problem, it will affect study, life and even employment. Take good care of your child’s eyes to have a bright future. Protecting eyesight is easier said than done, but it is not so simple to do. In the “Internet +” era, children use computers and mobile phones frequently. In addition to the epidemic for more than two years, many children take online classes, which has aggravated the incidence of myopia. In such a situation, if the drug can help relieve myopia, of course, parents will not ask for it.

The reason why the sale of atropine eye drops in Internet hospitals has caused controversy is that the drug has not been approved for marketing in China through strict clinical trials. Based on safety considerations, in some hospitals, in-hospital preparations are prescribed by doctors to young myopic children, and sales through the Internet are “convenient” for buyers, but there may be lax prescription review and expansion of the scope of use. , Increase the risk of difficulty in follow-up and observation, and lay down unpredictable hidden dangers. Because of this, professionals believe that the suspension of online sales of atropine eye drops is conducive to standardized use. Atropine eye drops can only be purchased with a prescription, which is equivalent to strengthening the doctor’s role as a gatekeeper, which is conducive to monitoring the effect of medication and standardizing the management of myopia diagnosis and treatment procedures for young people. .

Atropine eye drops, regarded as the “magic medicine for myopia”, can relieve myopia to a certain extent, but it cannot reverse myopia and has certain side effects. Drugs are only one aspect of treating myopia. The most fundamental thing is to maintain good eye habits, increase outdoor activities, reduce dependence on electronic products, and let the eyes rest.

Of course parents need to treat the “myopia magic medicine” rationally, but the panic buying and stockpiling of medicines caused by the “stop sale” also reminds the regulatory authorities. Nowadays, there are various so-called myopia control or treatment products on the market, which just hit the anxiety of parents, resulting in the mentality of going to the doctor in a hurry, and these high-priced but difficult to distinguish true and false products have formed A mixed situation has exacerbated the anxiety and blindness of parents.

For the health of children and the legitimate rights and interests of consumers, relevant departments should claim their responsibilities in a timely manner, take the initiative to rectify governance, regulate the market, and provide authoritative guidance information, so as not to let parents be thrown off balance.

Disclaimer: The above content is transferred from other media by this website. The relevant information is only for the purpose of conveying more information. It does not represent the views of this website, nor does it mean that this website agrees with its views or confirms its content. Authenticity, if there is any infringement, please contact (0531) 8519 6822.